Integrated Pharmacovigilance System for CM-Induced Adverse Reactions

Begaud B Chaslerie A Haramburu F : Organization et résultat de la pharmacovigilance en France. Rev Epidémiol Santé Publique 42: 416–423, 1994.

Edwards IR : Who cares about pharmacovigilance? Eur J Clin Pharmacol 53: 83–88, 1997.

Delamothe T : Reporting adverse drug reactions. Br Med J 304: 465, 1992.

Olsson S : The role of the WHO programme on international drug monitoring in coordinating worldwide drug safety efforts. Drug safety 19: 1–10, 1998.

Lumley CE Walker SR Hall GC : The under-reporting of adverse reactions seen in general practice. Pharm Med 1: 205–212, 1986.

Haramburu F : Estimation of under-reporting. In: Ed ARME-P . Methodological approaches in pharmacoepidemiology. Application to spontaneous reporting. Elsevier Science Publishers 1993: 39–49.

Moride Y Haramburu F Requejo AA : Under-reporting of adverse drug reactions in general practice. Br J Clin Pharmacol 43: 177–181, 1997.

Sweis D Wong ICK : A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Saf 2: 165–72, 2000.

van Grootheest K Mes Kyros Lolkje de Jong-Van den Berg LTW : Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting. Int J Pharm Pr 10: 267–72, 2002.

van Grootheest AC van Puijenbroek EP de Jong-Van den Berg LTW : Contribution of pharmacists to the reporting of adverse drug reactions. Pharmacoepidemiol. Drug Saf 11: 205–10, 2002.

FDA: Guidelines for postmarketing reporting of adverse drug experiences. Department of Health and Human Services 1992: 85D–0249.

Accreditation Manual for Hospitals: Joint Commission on Accreditation of Healthcare Organizations. Oakbrook Terrace, Ill 1993.

Standards of Practice: Canadian Society of Hospital Pharmacists 1990.

ASHP guidelines on adverse drug reaction monitoring and reporting: Practice Standards of ASHP 1992–1993. American Society of Hospital Pharmacists, Bethesda MD 1992.